FGF2 alters expression of the pyrophosphate/phosphate regulating proteins, PC-1, ANK and TNAP, in the calvarial osteoblastic cell line, MC3T3E1(C4)

Connective Tissue Research

Volumn 46, Issue 4-5, 2005, Pages 184-192

  Hatch, Nan E ^a   Nociti, Francisco ^b   Swanson, Erica ^a   Bothwell, Mark ^a   Somerman, Martha ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Bone mineralization; Growth factors; Molecular pathways; Osteoblasts; Pyrophosphate

Indexed keywords

ALKALINE PHOSPHATASE; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR; MEMBRANE PROTEIN; MESSENGER RNA; NUCLEOTIDE PYROPHOSPHATASE; PYROPHOSPHATE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALVARIA; CELL CULTURE; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CRANIOFACIAL SYNOSTOSIS; DOWNSTREAM PROCESSING; HYPOTHESIS; MINERALIZATION; MOUSE; NONHUMAN; OSTEOBLAST; PHOSPHATE METABOLISM; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; UPREGULATION;

ALKALINE PHOSPHATASE; ANIMALS; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; CELL LINE; CRANIOSYNOSTOSES; DIPHOSPHATES; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MEMBRANE PROTEINS; MICE; OSTEOBLASTS; PHOSPHATES; PHOSPHORIC DIESTER HYDROLASES; PYROPHOSPHATASES; RECEPTORS, FIBROBLAST GROWTH FACTOR; RNA, MESSENGER; SIGNAL TRANSDUCTION; SKULL; UP-REGULATION;

ANIMALIA;

EID: 33645116877     PISSN: 03008207     EISSN: 16078438     Source Type: Journal    
DOI: 10.1080/03008200500237203     Document Type: Article

References (45)

1. Moerlooze, L. and Dickson, C. (1997) Skeletal disorders associated with fibroblast growth factor receptor mutations Curr. Op. Gen. Dev., 7, pp. 378-385. [CSA]
2. Ornitz, D. and Marie, P. (2002) FGF Signaling in endochondral and intramembranous bone development and human genetic disease Genes Dev., 16, pp. 1446-1465. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
3. Marie, P. (2003) Fibroblast growth factor signaling controlling osteoblast differentiation Gene, 316, pp. 23-32. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
4. 32Pi uptake and mineralization by matrix vesicle-enriched fractions and by hydroxyapatite Bone, 6, pp. 307-312. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
5. Anderson, H. and Sipe, J. and Hessle, L. and Dhamyamraju, R. and Atti, E. and Camacho, N. and Millan, J. (2004) Impaired calcification around matrix vesicles of growth plate and bone in alkaline phosphatase-deficient mice Am. J. Path., 164, pp. 841-847. [PUBMED] [INFOTRIEVE] [CSA]
6. Terkeltaub, R. and Rosenbach, M. and Fong, F. and Goding, J. (1994) Causal link between nucleotide pyrophosphohydrolase over activity and increased intracellular inorganic pyrophosphate generation demonstrated by transfection of cultured fibroblasts and osteoblasts with plasma cell membrane glyoprotein-1 Arthrit. Rheum., 37, pp. 934 - 941. [CSA]
7. Fleisch, H. and Straumann, F. and Schenk, R. and Bisaz, S. and Allgower, M. (1966) Effect of condensed phosphates on calcification of chick embryo femurs in tissue culture Am. J. Physiol., 211, pp. 821-825. [PUBMED] [INFOTRIEVE] [CSA]
8. Johnson, K. and Moffa, A. and Chen, Y. and Prizker, K. and Goding, J. and Terkeltaub, R. (1999) Matrix vesicle plasma cell membrane glycoprotein-1 regulates mineralization by murine osteoblastic MC3T3 cells J. Bone Min. Res., 14, pp. 883-892. [CSA]
9. Johnson, K. and Hessle, L. and Vaingankar, S. and Wennerg, C. and Mauro, S. and Narisawa, S. and Goding, J. and Sano, K. and Millan, J. and Terkeltaub, R. (2000) Osteoblast tissue-nonspecific alkaline phosphatase antagonizs and regulates PC-1 Am. J. Physiol. Int. Comp. Physiol., 279, pp. 1365-R1377. [CSA]
10. Hessle, L. and Johnson, K. and Anderson, H. and Narisawa, S. and Sali, A. and Goding, J. and Terkeltaub, R. and Millan, J. (2002) Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization Proc. Nat. Acad. Sci., 99, pp. 9445-9449. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
11. Johnson, K. and Goding, J. and Van Etten, D. and Sali, A. and Hu, S. and Farley, D. and Krug, H. and Hessle, L. and Millan, J. and Terkeltaub, R. (2003) Linked deficiencies in extracellular PPi and osteopontin mediate pathologic calcification associated with defective PC-1 and ANK expression J. Bone Min. Res., 18, pp. 994 - 1004. [CSA]
12. Johnson, K. and Hashimoto, S. and Lotz, M. and Pritzker, K. and Goding, J. and Terkeltaub, R. (2001) Up-regulated expression of the phosphodiesterase nucleotide pyrophosphatase family member PC-1 is a marker and pathogenic factor for knee meniscal cartilage matrix calcification Arthritis Rheum., 44, pp. 1071-1081. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
13. Solan, J. and Deftos, L. and Goding, J. and Terkeltaub, R. (1996) Expression of the nucleoside triphosphate pyrophosphohydrolase PC-1 is induced by basic fibroblast growth factor (bFGF) and modulated by activation of the protein kinase A and C pathways in osteoblast-like osteosarcoma cells J. Bone Min. Res., 11, pp. 183-192. [CSA]
14. Terkeltaub, R. and Johnson, K. and Rohnow, D. and Goomer, R. and Burton, D. and Deftos, L. (1998) Bone morphogenetic proteins and bFGF exert opposing regulatory effects on PTHrP expression and inorganic pyrophosphate elaboration in immortalized murine endochondral hypertrophic chondrocytes (MCT cells) J. Bone Min. Res., 13, pp. 931-941. [CSA]
15. Wennberg, C. and Hessle, L. and Lundberg, P. and Mauro, S. and Narisawa, S. and Lerner, U. and Millan, J. (2000) Functional chracterization of osteoblasts and osteoclasts from alkaline phosphatase knockout mice J. Bone Min. Res., 15, pp. 1879-1888. [CSA]
16. Fedde, K. and Blair, L. and Silverstein, J. and Coburn, S. and Ryan, L. and Weinstein, R. and Waymire, K. and Narisawa, S. and Millan, J. and Macgregor, G. and Whyte, M. (1999) Alkaline phosphatase knock-out mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasia J. Bone Min. Res., 14, pp. 2015-2026. [CSA]
17. Reyes-Botella, C. and Ballecillo-Capilla, M. and Ruiz, C. (2002) Effect of different growth factors on human cultured osteoblast-like cells Cell Physiol. Biochem., 12, pp. 353 - 358. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
18. Pereira, R. and Exonomides, A. and Canalis, E. (2000) Bone morphogenetic proteins induce gremlin, a protein that limits their activity in osteoblasts Endocrinology, 141, pp. 4558-4563. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
19. Walsh, S. and Jefferiss, C. and Stewart, K. and Jordan, G. and Screen, J. and Beresford, J. (2000) Expression of the developmental markers STRO-1 and alkaline phosphatase in cultures of human marrow stromal cells: Regulation by fibroblast growth factor (FGF)-2 and relationship to the expression of FGF receptors 1-4 Bone, 27, pp. 185-195. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
20. Mansukhani, A. and Bellosta, P. and Sahni, M. and Basilico, C. (2000) Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts J. Bone Min. Res., 149, pp. 1297-1308. [CSA]
21. Debiais, F. and Hott, M. and Graulet, A. and Marie, P. (1998) The effects of fibroblast growth factor-2 on human neonatal calvarial osteoblastic cells are differentiation stage specific J. Bone Min. Res., 13, pp. 645-654. [CSA]
22. Pendleton, A. and Johnson, M. and Hughe, S and Gurley, K. and Ho, A. and Doherty, M. and Dixey, J. and Gillet, P. and Loeuille, D. and McGrath, R. and Reginato, A. and Shiang, R. and Wright, G. and Netter, P. and Williams, C. and Kingsley, D. (2002) Mutations in ANKH cause chondrocalcinosis Am. J. Hum. Gen., 71, pp. 933 - 940. [CSA] [CROSSREF]
23. Reichenberger, E. and Tiziani, V. and Watanabe, S. and Park, L. and Ueki, Y. and Santanne, C. and Baur, S. and Shiang, R. and Grange, D. and Beighton, B. and Garner, J. and Hamersma, H. and Sellars, S. and Ramesar, R. and Lidral, A. and Raposo do Amaral, C. and Gorlin, R. and Mulliken, J. and Olsen, B. (2001) Autosomal dominant craniometaphyseal dysplasia is caused by mutations in the transmembrane protein ANK Am. J. Hum. Gen., 68, pp. 1321-1326. [CSA] [CROSSREF]
24. Nurnberg, P. and Thiele, H. and Chandler, D. and Hohne, W. and Cunningham, M. and Ritter, H. and Leschik, G. and Uhlmann, K. and Mischung, C. and Harrop, K. and Goldblatt, J. and Borochowitz, Z. and Kotzot, D. and Westermann, F. and Mundlos, S. and Braun, H. and Laing, N. and Tinschert, S. (2001) Heterozygous mutations in ANKH, the human ortholog of the mouse progressive ankylosis gene, result in craniometaphyseal dysplasia Nat. Gen., 28, pp. 37-41. [CSA] [CROSSREF]
25. Ho, A. and Johnson, M. and Kingsley, D. (2000) Role of the mouse ank gene in control of tissue calcification and arthritis Science, 289, pp. 265-270. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
26. Sohn, P. and Crowley, M. and Slattery, E. and Serra, R. (2002) Developmental and TGF-β mediated regulation of Ank mRNA expression in cartilage and bone Osteoarthr. Cart., 10, pp. 482-490. [CSA] [CROSSREF]
27. Guo, Y. and Hsu, D. and Sheau-Line, Y. and Richards, C. and Winkles, J. (2002) Polypeptide growth factors and phorbol ester induce progressive ankylosis (ank) gene expression in murine and human fibroblasts J. Cell Biochem., 84, pp. 27-38. [CSA] [CROSSREF]
28. Choi, J. and Lee, B. and Song, K. and Park, R. and Kim, I. and Sohn, K. and Jo, J. and Ryoo, H. (1996) Expression patterns of bone-related proteins during osteoblastic differentiation in MC3T3-E1 cells J. Cell. Biochem., 61, pp. 609-618. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
29. Sudo, H. and Kodama, H. and Amagai, Y. and Yamamoto, S. and Kasai, S. (1983) In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria J. Cell. Bio., 96, pp. 191-198. [CSA] [CROSSREF]
30. Wang, D. and Christensen, K. and Chawla, K. and Xiao, G. and Krebsbach, P. and Franceschi, R. (1999) Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential J. Bone Min. Res., 14, pp. 893-903. [CSA]
31. Locklin, R. and Khosla, S. and Turner, R. and Biggs, B. (2003) Mediators of the biphasic response of bone to intermittent and continuously administered parathyroid hormone J. Cell. Biochem., 89, pp. 180-190. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
32. Hughes, F. and Collyer, J. and Stanfield, M. and Goodman, S. (1995) The effects of bone morphogenetic protein-2,-4 and -6 on differentiation of rat osteoblast cells in vitro Endocrinology, 136, pp. 2671-2677. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
33. Warren, S. and Brunet, L. and Harland, R. and Economides, A. and Longaker, M. (2003) The BMP antagonist noggin regulates cranial suture fusion Nature, 422, pp. 625-629. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
34. Xiao, G. and Gopalakrishman, R. and Jiang, D. and Reith, E. and Benson, M. and Franceschi, R. (2002) Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells J. Bone Min. Res., 17, pp. 101-110. [CSA]
35. Kalajzic, I. and Kalajzic, Z. and Hurley, M. and Lichtler, A. and Rowe, D. (2003) Stage specific inhibition of osteoblast lineage differentiation by FGF2 and noggin J. Cell. Biochem., 88, pp. 1168-1176. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
36. Burgar, H. and Burns, H. and Elsden, J. and Lalioti, M. and Heath, J. (2002) Association of the signaling adaptor FRS2 with fibroblast growth factor receptor 1 (Fgfr1) is mediated by alternative splicing of the juxtamembrane domain J. Bio. Chem., 277, pp. 4018-4123. [CSA] [CROSSREF]
37. Debiais, F. and Lemonnier, J. and Hay, E. and Delannoy, P. and Caverzasio, J. and Marie, P. (2001) Fibroblast growth factor-2 (FGF) increases N-cadherin expression through protein kinase C and src-kinase pathways in human calvarial osteoblasts J. Cell. Biochem., 81, pp. 68-81. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
38. Newberry, E. and Willis, D. and Latifi, T. and Boudreasux, J. and Towler, D. (1997) Fibroblast growth factor receptor signaling activates the human interstitial collagenase promoter via the bipartite Ets-AP1 element Mol. End., 11, pp. 1129-1144. [CSA] [CROSSREF]
39. Kim, H. and Kin, J. and Bae, S. and Choi, J. and Kim, H. and Ryoo, H. (2003) The protein kinase C pathway plays a central role in the FGF-stimulated expression and transactivation activity of run× 2 J. Biol. Chem., 278, pp. 319-326. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
40. Leclerc, C. and Duprat, A. and Moreau, M. (1999) Noggin upregulates fos expression by a calcium-mediated pathway in amphibian embryos Dev. Growth. Diff., 41, pp. 227-238. [CSA] [CROSSREF]
41. Rawadi, G. and Vayssiere, B. and Dunn, F. and Baron, R. and Roman-Roman, S. (2003) BMP-2 controls alkaline phosphates expression and osteoblast mineralization by a Wnt autocrine loop J. Bone Min. Res., 18, pp. 1842-1853. [CSA]
42. Whyte, M. and Landt, M. and Ryan, L. and Mulivor, R. and Henthorn, P. and Fedde, K. and Mahuren, J. and Coburn, S. (1999) Alkaline phosphatase: Placental and tissue-non-specific isoenzymes hydrolyze phosphoethanolamine, inorganic pyrophosphate, and pyridoxal 5′-phosphate. Substrate accumulation in carriers of hypophosphatasia corrects during pregnancy J Clin Inv., 95, pp. 1440-1445. [CSA]
43. Kreiborg, S. (1981) Crouzon syndrome: A clinical and roentgencephalometric study Scan. J. Plast. Reconstr. Surg., pp. 18. suppl [CSA]
44. Chen, L. and Cuiling, L. and Engel, A. and Deng, C. (2003) A Ser250Trp substitution in mouse fibroblast growth factor receptor (Fgfr2) results in craniosynostosis Bone, 33, pp. 169-178. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
45. Johnson, K. and Terkeltaub, R. (2004) Upregulated ank expression in osteoarthritis can promote both chondrocyte MMP-13 expression and calcification via chondrocyte extracellular PPi excess Osteoarthr. Cart., 12, pp. 321-335. [CSA] [CROSSREF]